Activ Surgical, Inc.

Activ Surgical, Inc. focuses on revolutionizing surgical procedures by creating innovative technologies that enhance intraoperative surgical intelligence and precision for surgeons. Founded in 2017 and headquartered in Boston, US, Activ Surgical, Inc. specializes in advanced surgical technologies.

The company was co-founded by Peter Kim and Seth Teicher. It has raised a total of USD 14. 57 mn from its latest Series B round, which was led by Hikma Ventures on March 22, 2022. Activ Surgical has completed seven funding rounds and currently holds a valuation of USD 182.

53 mn. Activ Surgical specializes in advanced surgical technologies, focusing primarily on intraoperative surgical intelligence through its flagship product, ActivSight™ Intelligent Light. This technology enables surgeons to visualize critical physiological structures and functions that are not discernible to the naked eye, leveraging augmented reality (AR), artificial intelligence (AI), and machine learning (ML) for real-time data. ActivSight is compatible with minimally invasive surgery (MIS) systems and caters to various surgical specialties including colorectal, thoracic, and bariatric surgery, with markets in North America and Europe.

Activ Surgical's revenue model is based on the sale and integration of its proprietary surgical technologies, particularly the ActivSight™ Intelligent Light. The products are sold directly to healthcare providers, including hospitals and surgical centers. The company engages in B2B relationships, providing tailored solutions designed to improve surgical outcomes and operational efficiency in healthcare institutions. In March 2022, Activ Surgical, Inc.

raised USD 14. 57 mn in Series B funding to support the expansion of its business. The funding will be utilized to roll out its ActivSight imaging module. The company is also focusing on developing new products and expanding into targeted markets and regions where advanced surgical procedures are prevalent.